welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europe and Japan
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europe and Japan
expertly curated content related to this topic
-
Laparoscopic Restorative Proctocolectomy: Case-Matched Comparative Study with Open Restorative ProctocolectomyPURPOSE : A laparoscopic approach to res...
-
Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps TrialOBJECTIVES: Subjects in the Prevention ...
-
Sapna Syngal, MD, MPHCurrent Positions: Director, Gastrointes...
-
Cell Proliferation and Apoptotic Indices Predict Adenoma Regression in a Placebo-Controlled Trial of Celecoxib in Fa...BACKGROUND : Celecoxib was shown to regr...
-
University of California, San Francisco Medical CenterPatient Resources: Center...
-
Kasia J. Bloch, BS, BA, MS, LGCGenetic Counselor Education: MS, Gene...
-
Outcome Based on Management for Duodenal Adenomas: Sporadic versus Familial DiseaseINTRODUCTION : Management and outcomes f...